3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, Mantle-Cell
15
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma
5
Lymphoma, B-Cell
3
Leukemia, B-Cell
3
Waldenstrom Macroglobulinemia
2
Lymphatic Diseases
2
Neoplasms
1
Neoplasm, Residual
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hematologic Diseases
1
Heart Failure
1
Glioblastoma
1
Burkitt Lymphoma
1
Anemia, Hemolytic, Autoimmune
1
Interventions
pembrolizumab
24
enfortumab vedotin
14
Nivolumab
14
Gemcitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Cisplatin
8
Carboplatin
8
sacituzumab govitecan
6
Docetaxel
6
avelumab
5
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
CTLA-4 Antigen
3
zanidatamab
2
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
acalabrutinib
×
90 days
×
Clear all
No trials found.